MonashHeart, Monash Health, Melbourne, VIC.
Monash Cardiovascular Research Centre, Monash University, Melbourne, VIC.
Med J Aust. 2020 Aug;213(4):182-187. doi: 10.5694/mja2.50714. Epub 2020 Jul 31.
The coronavirus 2019 disease (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pre-existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID-19, and COVID-19 itself causes serious cardiac sequelae. Strategies to minimise the risk of viral transmission to health care workers and uninfected cardiac patients while prioritising high quality cardiac care are urgently needed. We conducted a rapid literature appraisal and review of key documents identified by the Cardiac Society of Australia and New Zealand Board and Council members, the Australian and New Zealand Society of Cardiac and Thoracic Surgeons, and key cardiology, surgical and public health opinion leaders.
Common acute cardiac manifestations of COVID-19 include left ventricular dysfunction, heart failure, arrhythmias and acute coronary syndromes. The presence of underlying CVD confers a five- to tenfold higher case fatality rate with COVID-19 disease. Special precautions are needed to avoid viral transmission to this population at risk. Adaptive health care delivery models and resource allocation are required throughout the health care system to address this need.
Cardiovascular health services and cardiovascular health care providers need to recognise the increased risk of COVID-19 among CVD patients, upskill in the management of COVID-19 cardiac manifestations, and reorganise and innovate in service delivery models to meet demands. This consensus statement, endorsed by the Cardiac Society of Australia and New Zealand, the Australian and New Zealand Society of Cardiac and Thoracic Surgeons, the National Heart Foundation of Australia and the High Blood Pressure Research Council of Australia summarises important issues and proposes practical approaches to cardiovascular health care delivery to patients with and without SARS-CoV-2 infection.
2019 年冠状病毒病(COVID-19)大流行是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的。先前存在的心血管疾病(CVD)会增加 COVID-19 的发病率和死亡率,而 COVID-19 本身会导致严重的心脏后遗症。当务之急是制定策略,尽量减少病毒传播给医护人员和未感染的心脏患者的风险,同时优先考虑高质量的心脏护理。我们对澳大利亚和新西兰心脏病学会理事会和董事会成员、澳大利亚和新西兰心胸外科医师学会以及主要的心脏病学、外科学和公共卫生意见领袖确定的关键文件进行了快速文献评估和综述。
COVID-19 的常见急性心脏表现包括左心室功能障碍、心力衰竭、心律失常和急性冠状动脉综合征。患有基础 CVD 的患者 COVID-19 疾病的病死率增加五至十倍。需要采取特殊预防措施,避免将这种高危人群暴露于病毒之下。整个医疗体系需要适应卫生保健服务交付模式和资源配置,以满足这一需求。
心血管保健服务和心血管保健提供者需要认识到 CVD 患者感染 COVID-19 的风险增加,需要提高 COVID-19 心脏表现的管理技能,并对服务交付模式进行重组和创新,以满足需求。本共识声明由澳大利亚和新西兰心脏病学会、澳大利亚和新西兰心胸外科医师学会、澳大利亚国家心脏基金会和澳大利亚高血压研究理事会共同认可,总结了重要问题,并提出了针对 SARS-CoV-2 感染患者和非感染患者的心血管保健服务的实用方法。